These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 12658269)

  • 1. Janus-like role of regulatory iNKT cells in autoimmune disease and tumour immunity.
    Wilson SB; Delovitch TL
    Nat Rev Immunol; 2003 Mar; 3(3):211-22. PubMed ID: 12658269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Innate immunity modulates autoimmunity: type 1 interferon-beta treatment in multiple sclerosis promotes growth and function of regulatory invariant natural killer T cells through dendritic cell maturation.
    Gigli G; Caielli S; Cutuli D; Falcone M
    Immunology; 2007 Nov; 122(3):409-17. PubMed ID: 17617156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Invariant natural killer T cells and immunotherapy of cancer.
    Molling JW; Moreno M; van der Vliet HJ; van den Eertwegh AJ; Scheper RJ; von Blomberg BM; Bontkes HJ
    Clin Immunol; 2008 Nov; 129(2):182-94. PubMed ID: 18783990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic potential of CD1d-restricted invariant natural killer T cell-based treatment for autoimmune diseases.
    Miyake S; Yamamura T
    Int Rev Immunol; 2007; 26(1-2):73-94. PubMed ID: 17454265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Invariant natural killer T cells: innate-like T cells with potent immunomodulatory activities.
    Wu L; Gabriel CL; Parekh VV; Van Kaer L
    Tissue Antigens; 2009 Jun; 73(6):535-45. PubMed ID: 19392798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD1d-restricted glycolipid antigens: presentation principles, recognition logic and functional consequences.
    Florence WC; Bhat RK; Joyce S
    Expert Rev Mol Med; 2008 Jul; 10():e20. PubMed ID: 18601810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytokine-dependent modification of IL-12p70 and IL-23 balance in dendritic cells by ligand activation of Valpha24 invariant NKT cells.
    Uemura Y; Liu TY; Narita Y; Suzuki M; Nakatsuka R; Araki T; Matsumoto M; Iwai LK; Hirosawa N; Matsuoka Y; Murakami M; Kimura T; Hase M; Kohno H; Sasaki Y; Ichihara Y; Ishihara O; Kikuchi H; Sakamoto Y; Jiao SC; Senju S; Sonoda Y
    J Immunol; 2009 Jul; 183(1):201-8. PubMed ID: 19542431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Invariant and noninvariant natural killer T cells exert opposite regulatory functions on the immune response during murine schistosomiasis.
    Mallevaey T; Fontaine J; Breuilh L; Paget C; Castro-Keller A; Vendeville C; Capron M; Leite-de-Moraes M; Trottein F; Faveeuw C
    Infect Immun; 2007 May; 75(5):2171-80. PubMed ID: 17353286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Invariant NKT cells and tolerance.
    Nowak M; Stein-Streilein J
    Int Rev Immunol; 2007; 26(1-2):95-119. PubMed ID: 17454266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. alpha-Galactosylceramide therapy for autoimmune diseases: prospects and obstacles.
    Van Kaer L
    Nat Rev Immunol; 2005 Jan; 5(1):31-42. PubMed ID: 15630427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The dangerous liaison between iNKT cells and dendritic cells: does it prevent or promote autoimmune diseases?
    Caielli S; Sorini C; Falcone M
    Autoimmunity; 2011 Feb; 44(1):11-22. PubMed ID: 20672910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Understanding the behavior of invariant NKT cells in autoimmune diseases.
    Yamamura T; Sakuishi K; Illés Z; Miyake S
    J Neuroimmunol; 2007 Nov; 191(1-2):8-15. PubMed ID: 17905445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of invariant NKT cells by toll-like receptor 9-stimulated dendritic cells requires type I interferon and charged glycosphingolipids.
    Paget C; Mallevaey T; Speak AO; Torres D; Fontaine J; Sheehan KC; Capron M; Ryffel B; Faveeuw C; Leite de Moraes M; Platt F; Trottein F
    Immunity; 2007 Oct; 27(4):597-609. PubMed ID: 17950005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Innate Valpha14(+) natural killer T cells mature dendritic cells, leading to strong adaptive immunity.
    Fujii S; Shimizu K; Hemmi H; Steinman RM
    Immunol Rev; 2007 Dec; 220():183-98. PubMed ID: 17979847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Co-inhibitory roles for glucocorticoid-induced TNF receptor in CD1d-dependent natural killer T cells.
    Chen S; Ndhlovu LC; Takahashi T; Takeda K; Ikarashi Y; Kikuchi T; Murata K; Pandolfi PP; Riccardi C; Ono M; Sugamura K; Ishii N
    Eur J Immunol; 2008 Aug; 38(8):2229-40. PubMed ID: 18624295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The immunoregulatory role of CD1d-restricted natural killer T cells in disease.
    van der Vliet HJ; Molling JW; von Blomberg BM; Nishi N; Kölgen W; van den Eertwegh AJ; Pinedo HM; Giaccone G; Scheper RJ
    Clin Immunol; 2004 Jul; 112(1):8-23. PubMed ID: 15207777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aging is associated with a rapid decline in frequency, alterations in subset composition, and enhanced Th2 response in CD1d-restricted NKT cells from human peripheral blood.
    Jing Y; Gravenstein S; Chaganty NR; Chen N; Lyerly KH; Joyce S; Deng Y
    Exp Gerontol; 2007 Aug; 42(8):719-32. PubMed ID: 17368996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The in vivo response of invariant natural killer T cells to glycolipid antigens.
    Parekh VV; Lalani S; Van Kaer L
    Int Rev Immunol; 2007; 26(1-2):31-48. PubMed ID: 17454263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunotherapeutic potential for ceramide-based activators of iNKT cells.
    Berkers CR; Ovaa H
    Trends Pharmacol Sci; 2005 May; 26(5):252-7. PubMed ID: 15860372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation and sustained expansion of mouse spleen invariant NKT cell lines with preserved cytokine releasing capacity.
    Molling JW; Moreno M; van der Vliet HJ; von Blomberg BM; van den Eertwegh AJ; Scheper RJ; Bontkes HJ
    J Immunol Methods; 2007 Apr; 322(1-2):70-81. PubMed ID: 17343874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.